Chemours Q2 2026: Net loss $274M, Adj. EPS $0.42, revenue flat at $1.6B

Chemours Co

Net loss $274M ($1.81/sh) vs $380M loss ($2.53/sh) prior year; adjusted net income $64M ($0.42/sh) vs $91M ($0.61/sh).
Net sales $1.6B flat YoY; Adjusted EBITDA $247M vs $260M prior year.
Free cash flow improved 128% YoY; net leverage declined to 4.4x; free cash flow conversion 46%.
Announced global TiO2 price increase effective June 1, 2026; APM Performance Solutions sales up 8% YoY.
CEO Denise Dignam cites disciplined execution and progress on balance sheet and legacy litigation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.